| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.1 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.31 | 0.1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.1 |